- Home
- ADAP vs BNGO Comparison
ADAP vs BNGO Comparison
Compare ADAP & BNGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ADAP
- BNGO
- Stock Information
- Founded
- ADAP 2008
- BNGO 2003
- Country
- ADAP United Kingdom
- BNGO United States
- Employees
- ADAP N/A
- BNGO N/A
- Industry
- ADAP Biotechnology: Pharmaceutical Preparations
- BNGO Biotechnology: Laboratory Analytical Instruments
- Sector
- ADAP Health Care
- BNGO Industrials
- Exchange
- ADAP Nasdaq
- BNGO Nasdaq
- Market Cap
- ADAP 21.3M
- BNGO 24.3M
- IPO Year
- ADAP 2015
- BNGO 2018
- Fundamental
- Price
- ADAP $0.06
- BNGO $4.00
- Analyst Decision
- ADAP Hold
- BNGO Buy
- Analyst Count
- ADAP 6
- BNGO 5
- Target Price
- ADAP $1.02
- BNGO $7.67
- AVG Volume (30 Days)
- ADAP 89.0M
- BNGO 138.6K
- Earning Date
- ADAP 08-13-2025
- BNGO 08-14-2025
- Dividend Yield
- ADAP N/A
- BNGO N/A
- EPS Growth
- ADAP N/A
- BNGO N/A
- EPS
- ADAP N/A
- BNGO N/A
- Revenue
- ADAP $65,084,999.00
- BNGO $27,426,000.00
- Revenue This Year
- ADAP N/A
- BNGO N/A
- Revenue Next Year
- ADAP $52.35
- BNGO $15.54
- P/E Ratio
- ADAP N/A
- BNGO N/A
- Revenue Growth
- ADAP N/A
- BNGO N/A
- 52 Week Low
- ADAP $0.05
- BNGO $2.68
- 52 Week High
- ADAP $1.33
- BNGO $33.72
- Technical
- Relative Strength Index (RSI)
- ADAP 29.42
- BNGO 70.52
- Support Level
- ADAP $0.05
- BNGO $2.98
- Resistance Level
- ADAP $0.09
- BNGO $4.23
- Average True Range (ATR)
- ADAP 0.01
- BNGO 0.21
- MACD
- ADAP 0.00
- BNGO 0.12
- Stochastic Oscillator
- ADAP 7.21
- BNGO 83.09
About ADAP Adaptimmune Therapeutics plc
Adaptimmune Therapeutics PLC is a commercial-stage biopharmaceutical company working to redefine the treatment of solid tumor cancers with cell therapies. It has developed a comprehensive proprietary platform that enables it to identify cancer targets, find and genetically engineer T-cell receptors, and produce TCR therapeutic candidates for administration to patients. Its programs include MAGE-A4 SPEAR T-cell therapy, NY-ESO SPEAR T-cell, CD70, and others for multiple cancer types.
About BNGO Bionano Genomics Inc.
Bionano Genomics Inc is a life sciences instrumentation company in the genome analysis space. It is engaged in the development and marketing of the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline the study of changes in chromosomes. Geographically, it operates in Americas, EMEA and Asia Pacific; majority revenue being generated from Americas. They generate product revenue from sales of its OGM and Ionic Purification systems and consumables, which includes its instruments, and their VIA software.